These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 101878)

  • 21. [Characterization of drug, narcotic and psychotropic drug chirality by statistical methods].
    Noszál B; Schiller Z
    Acta Pharm Hung; 1999 Apr; 69(2):85-90. PubMed ID: 10389303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico human and rat Vss quantitative structure-activity relationship models.
    Gleeson MP; Waters NJ; Paine SW; Davis AM
    J Med Chem; 2006 Mar; 49(6):1953-63. PubMed ID: 16539383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The dangers of drug use in the aged--implications of changed pharmacokinetics and pharmacodynamics for correct indications and dosage].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1977 Oct; 121(42):1660-1. PubMed ID: 904724
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacodynamic principles in chemical teratology: dose-effect relationships.
    Jusko WJ
    J Pharmacol Exp Ther; 1972 Dec; 183(3):469-80. PubMed ID: 4636387
    [No Abstract]   [Full Text] [Related]  

  • 25. [Advances in drug design].
    Guo ZR
    Sheng Li Ke Xue Jin Zhan; 1984 Jul; 15(3):238-44. PubMed ID: 6393337
    [No Abstract]   [Full Text] [Related]  

  • 26. Predicting human pharmacokinetics from preclinical data.
    Poggesi I
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):100-11. PubMed ID: 14982153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simple method for prediction and estimation of the hemodialysability of incorporated drugs.
    Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):217-22. PubMed ID: 4021653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How drugs act.
    Jones B
    Nurs Mirror; 1984 May; 158(19):17-9. PubMed ID: 6563602
    [No Abstract]   [Full Text] [Related]  

  • 29. Mathematical model of dose-activity relationships.
    Franke R; Oehme P; Barth A
    Environ Qual Saf Suppl; 1975; 3():461-66. PubMed ID: 1063665
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of pharmacologically active metabolites in drug discovery and development.
    Fura A
    Drug Discov Today; 2006 Feb; 11(3-4):133-42. PubMed ID: 16533711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New orientations in medicine: cellular receptors in therapeutics. I. Introduction].
    Sepúlveda B
    Gac Med Mex; 1981 Dec; 117(12):463-5. PubMed ID: 7044868
    [No Abstract]   [Full Text] [Related]  

  • 33. A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry.
    Martin YC
    J Med Chem; 1981 Mar; 24(3):229-37. PubMed ID: 7265109
    [No Abstract]   [Full Text] [Related]  

  • 34. Thermodynamic analysis of structure-activity relationships of drugs. Prediction of optimal structure.
    Higuchi T; Davis SS
    J Pharm Sci; 1970 Oct; 59(10):1376-83. PubMed ID: 5471939
    [No Abstract]   [Full Text] [Related]  

  • 35. Chromatographic hydrophobic parameters in correlation analysis of structure-activity relationships.
    Tomlinson E
    J Chromatogr; 1975 Mar; 113(1):1-45. PubMed ID: 1094027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity considerations: a synthesis of ideas.
    Hathway DE
    Chem Biol Interact; 1982 Oct; 42(1):1-26. PubMed ID: 7151222
    [No Abstract]   [Full Text] [Related]  

  • 37. Chromatography in studies of quantitative structure-activity relationships.
    Kaliszan R
    J Chromatogr; 1981 May; 220(1):71-83. PubMed ID: 7026584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity studies on halluncinogenic amphetamines using model interaction calculations.
    Dipaolo T; Hall LH; Kier LB
    J Theor Biol; 1978 Apr; 71(3):295-309. PubMed ID: 642532
    [No Abstract]   [Full Text] [Related]  

  • 39. Isosterism and competitive phenomena in drugs; a study of structure-activity relationships in agents acting upon autonomic effector cells.
    BOVET D
    Science; 1959 May; 129(3358):1255-64. PubMed ID: 13658953
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of a physical multi-cell model to confirm theoretical predictions of biphasic structure-activity relationships [proceedings].
    Dearden JC; Patel KD
    J Pharm Pharmacol; 1978 Dec; 30 Suppl():51P. PubMed ID: 32308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.